Call us for Counseling - 9580048004, For Support - 8860807050.  

Tags Current Affairs

Diabetes drug shows promise on Covid-19 lung effects

Date: 16 June 2021 Tags: Miscellaneous


Studies have shown that metformin drug used in diabetes treatment has the ability to reduce lung inflammation in mice infected with SARS CoV-2 virus.



The drug, metformin, is used in early therapy for diabetes type-2 condition as it can lower sugar in blood.



  • The researchers from University of California San Diego (UCSD) were studying the anti-inflammatory mechanism showed by the metformin drug in mice models.

  • To check the efficacy of the drug, they selected mice showing acute respiratory distress syndrome (ARDS). In this condition, fluids leak into the lungs and causes difficulty in breathing.

  • The acute respiratory distress syndrome (ARDS) was a major reason for death of patients admitted in hospitals due to Covid-19 infection.

  • The mice were administered metformin drug before or after exposure to the bacteria that caused pneumonia.

  • The drug was able to restrict the onset of symptoms of acute respiratory distress syndrome (ARDS) and reduce pulmonary inflammation. Mortality rate also decreased significantly.

Notice (8): Undefined variable: quizpole [ROOT/plugins/Studyiq/src/Template/Pages/tagdetails.ctp, line 161]